Cardiac tamponade is a dangerous complication that can arise rapidly after heart surgery, often during the critical hours in intensive care. Diagnosing it early remains a major challenge due to its subtle and easily misinterpreted signs. That’s why Birmingham-based Fallouh Healthcare is developing PerDeCT™, a novel device designed to provide real-time monitoring and early detection of tamponade.
Backed by a £305,050 grant from Innovate UK under the Eureka Eurostars programme, Fallouh Healthcare is partnering with the Medical University of Vienna to finalise the prototype. The device is inserted during surgery and combines a balloon and probe placed in the pericardium to monitor cardiac output. By analysing the changes in heart function as the balloon inflates, PerDeCT can detect early signs of tamponade, well before symptoms appear.
Unlike traditional monitoring systems, PerDeCT is simple, low-cost, and removable through the skin once recovery is complete. It addresses a critical gap in post-surgical cardiac care, offering clinicians a much-needed tool to act before complications escalate.
Dr. Hazem Fallouh, founder and experienced cardiothoracic surgeon, explains: “As many as 3 in 10 of all deaths that immediately follow post-cardiac surgery are thought to be due to tamponade and we are confident the device can save lives, improve patient outcomes, and reduce the overall costs of cardiac surgery.”
With clinical trials planned in the UK and Austria, PerDeCT is on track to become a key player in the future of cardiac post-op monitoring.
Article written by EIN Presswire team
18/06/2025
Source:
EIN Presswire